Inclisiran is a small interfering RNA (siRNA) therapeutic that silences the production of PCSK9 in the liver. Functionally, the result is the same as the monoclonal antibody PCSK9 inhibitors (evolocumab, alirocumab): more LDL receptors on hepatocyte…